Nov 13, 2026Novo submits sickle cell drug for regulatory approvalNovo Nordisk has submitted a sickle cell disease drug for regulatory approval, a medicine acquired in a billion-dollar deal that the company views as a future blockbuster.Nov 13, 2026·2 sources00